Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

256 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
A short course of induction chemotherapy followed by two cycles of high-dose chemotherapy with stem cell rescue for chemotherapy naive metastatic breast cancer: sequential phase I/II studies.
Elias AD, Richardson P, Avigan D, Ibrahim J, Joyce R, McDermott D, Levine J, Warren D, McCauley M, Wheeler C, Frei E 3rd. Elias AD, et al. Among authors: joyce r. Bone Marrow Transplant. 2001 Sep;28(5):447-54. doi: 10.1038/sj.bmt.1703148. Bone Marrow Transplant. 2001. PMID: 11593317 Clinical Trial.
Selective in vivo mobilization with granulocyte macrophage colony-stimulating factor (GM-CSF)/granulocyte-CSF as compared to G-CSF alone of dendritic cell progenitors from peripheral blood progenitor cells in patients with advanced breast cancer undergoing autologous transplantation.
Avigan D, Wu Z, Gong J, Joyce R, Levine J, Elias A, Richardson P, Milano J, Kennedy L, Anderson K, Kufe D. Avigan D, et al. Among authors: joyce r. Clin Cancer Res. 1999 Oct;5(10):2735-41. Clin Cancer Res. 1999. PMID: 10537336
A short course of induction chemotherapy followed by two cycles of high-dose chemotherapy with stem cell rescue for chemotherapy naive metastatic breast cancer.
Elias AD, Richardson P, Avigan D, Ibrahim J, Joyce R, Demetri G, Levine J, Warren D, Arthur T, Reich E, Wheele C, Frei E 3rd, Ayash L. Elias AD, et al. Among authors: joyce r. Bone Marrow Transplant. 2001 Feb;27(3):269-78. doi: 10.1038/sj.bmt.1702780. Bone Marrow Transplant. 2001. PMID: 11277174 Clinical Trial.
The impact of induction duration and the number of high-dose cycles on the long-term survival of women with metastatic breast cancer treated with high-dose chemotherapy with stem cell rescue: an analysis of sequential phase I/II trials from the Dana-Farber/Beth Israel STAMP program.
Elias AD, Ibrahim J, Richardson P, Avigan D, Joyce R, Reich E, McCauley M, Wheeler C, Frei E 3rd. Elias AD, et al. Among authors: joyce r. Biol Blood Marrow Transplant. 2002;8(4):198-205. doi: 10.1053/bbmt.2002.v8.pm12017145. Biol Blood Marrow Transplant. 2002. PMID: 12017145 Free article. Clinical Trial.
A phase I-II study of rituximab, ifosfamide, mitoxantrone and etoposide (R-IME) for B cell non-Hodgkin's lymphoma prior to and after high-dose chemotherapy and autologous stem cell transplantation (HDC-ASCT).
Joyce RM, Regan M, Ottaway J, Umiel T, Tetreault JC, Levine J, McDermott D, Hurley D, Giallombardo N, Smith T, Lamontagne D, Uhl L, Avigan D. Joyce RM, et al. Ann Oncol. 2003;14 Suppl 1:i21-7. doi: 10.1093/annonc/mdg705. Ann Oncol. 2003. PMID: 12736227 Free article. Clinical Trial.
256 results